Congestive Heart Failure News and Research

RSS

Congestive Heart Failure is a condition in which the heart can't pump blood the way it should. In some cases, the heart can't fill with enough blood. In other cases, the heart can't send blood to the rest of the body with enough force. Some people have both problems. "Heart failure" doesn't mean that your heart has stopped or is about to stop working. However, it's a serious condition that requires medical care. Heart failure develops over time as the pumping of the heart grows weaker. It can affect the right side of the heart only or both the left and right sides of the heart. Most cases involve both sides of the heart.

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA Department of Urology.

21 May 2013

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).

16 May 2013

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma who have progressed on Nexavar (sorafenib) tablets, an anticancer medicine for the treatment of patients with unresectable HCC.

15 May 2013

Blue Cross Blue Shield Foundation honors Beaumont cardiologist for improving health care in Michigan

Kavitha Chinnaiyan, M.D., director of Advanced Cardiac Imaging Education at Beaumont Hospital, Royal Oak, has received the Frank J. McDevitt, D.O., Award for Excellence in Health Policy Research for Physicians.

14 May 2013

Combinations of sEH inhibition and PPARγ activation have beneficial effects on cardiometabolic syndrome

Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with tAUCB (trans-4-(4-[3-adamantan-1-yl-ureid]-cyclohexyloxy)-benzoic acid) and activating peroxisome proliferator-activator receptorγ (PPARγ) with the thiazolidinedione rosiglitazone on the pathological progression of cardiometabolic syndrome.

25 Apr 2013

Reducing preventable hospital readmissions may take longer, say researchers

Achieving widespread reductions in preventable hospital readmissions among Medicare beneficiaries may take longer than many health care professionals originally anticipated, according to researchers at Penn State, the Weill Cornell Medical College and the University of Pennsylvania.

18 Apr 2013

EKG could predict cardiovascular illness

A common test that records the heart's electrical activity could predict potentially serious cardiovascular illness, according to a UC San Francisco-led study.

17 Apr 2013

UI Health to launch EPIC program to cut frequent ER visits, readmissions to hospital

The University of Illinois Hospital & Health Sciences System is taking steps to reduce frequent emergency room visits and readmissions to the hospital.

17 Apr 2013

Large numbers of ER visits go unreported in calculating hospital readmission rates

A study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and Boston University School of Medicine has found that nearly one quarter of patients may return to the emergency department within 30 days of being discharged from a hospitalization.

17 Apr 2013

Sorbent Therapeutics starts patient dosing in Phase 2b clinical trial of CLP-1001

Sorbent Therapeutics, Inc., a biopharmaceutical company developing therapies for cardiovascular and renal diseases, today announced that patient dosing has commenced in its Phase 2b clinical trial of CLP-1001.

12 Apr 2013

Weight loss and heart damage: an interview with Dr Lili Barouch, Johns Hopkins University School of Medicine

Obesity causes an increase in the stiffness of the heart, making it hard for the heart muscle to relax and fill with blood in between heartbeats. This abnormal stiffness can lead to congestive heart failure and other problems as it becomes more severe.

4 Apr 2013

Death rates on the rise at some rural hospitals

A new study finds that these critical access hospitals, which are exempt from reporting certain quality and outcomes data to the federal government, are not matching the gains made by other facilities regarding mortality rates after treatment for heart attacks, heart failure and pneumonia.

4 Apr 2013

Study finds high mortality rates in rural hospitals

In an analysis that included data on more than 10 million Medicare beneficiaries admitted to acute care hospitals with a heart attack, congestive heart failure, or pneumonia between 2002 and 2010, 30-day mortality rates for those admitted to critical access hospitals (designated hospitals that provide inpatient care to individuals living in rural communities) increased during this time period compared with patients admitted to other acute care hospitals, according to a study in the April 3 issue of JAMA.

3 Apr 2013

Translational Research's April issue examines progress, outlook of gene therapy research

The April issue of Translational Research examines the progress and outlook of gene therapy research, with a specific focus on the clinical applicability of gene therapy today.

22 Mar 2013

Post-discharge activity level linked to risk of hospital readmission in elderly

A new study has found a link between the activity levels of elderly people who have just been released from the hospital and the risk that they will require readmission within 30 days.

14 Mar 2013

STREAM trial: Treatment with tenecteplase before hospital transfer benefits some

A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.

13 Mar 2013

Quitting smoking linked with lower risk of cardiovascular disease among adults without diabetes

Among adults without diabetes, quitting smoking, compared with continuing smoking, was associated with a lower risk of cardiovascular disease despite subsequent weight gain, according to a study appearing in the March 13 issue of JAMA.

13 Mar 2013

CellAegis Devices to use autoRIC Device for Chronic Remote Ischemic Conditioning

CellAegis Devices, Inc., announced today that it has received an Investigational Testing Approval from Health Canada that allows the initiation of clinical testing in Canada of the Company's autoRIC Device for Chronic Remote Ischemic Conditioning (CRIC).

27 Feb 2013

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

One way to contain health care spending is to get patients involved in weighing costs of treatment options with their doctors. Researchers recruited 211 medically insured participants to assess their willingness to consider costs when choosing treatments. The authors found that participants generally "preferred better care, even when the relative benefit it offered was marginal, and even when told that the second-best choice still met the threshold of 'good enough' care from a clinician's perspective.

26 Feb 2013

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB announced today two new regulatory filings with the US Food and Drug Administration (FDA) and with the European Medicines Agency (EMA) to extend the marketing authorization for Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA) and for adult patients with active axial spondyloarthritis (axSpA).

20 Feb 2013

Congestive Heart Failure News and Research

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Blue Cross Blue Shield Foundation honors Beaumont cardiologist for improving health care in Michigan

Combinations of sEH inhibition and PPARγ activation have beneficial effects on cardiometabolic syndrome

Reducing preventable hospital readmissions may take longer, say researchers

EKG could predict cardiovascular illness

UI Health to launch EPIC program to cut frequent ER visits, readmissions to hospital

Large numbers of ER visits go unreported in calculating hospital readmission rates

Sorbent Therapeutics starts patient dosing in Phase 2b clinical trial of CLP-1001

Weight loss and heart damage: an interview with Dr Lili Barouch, Johns Hopkins University School of Medicine

Death rates on the rise at some rural hospitals

Study finds high mortality rates in rural hospitals

Translational Research's April issue examines progress, outlook of gene therapy research

Post-discharge activity level linked to risk of hospital readmission in elderly

STREAM trial: Treatment with tenecteplase before hospital transfer benefits some

Quitting smoking linked with lower risk of cardiovascular disease among adults without diabetes

CellAegis Devices to use autoRIC Device for Chronic Remote Ischemic Conditioning

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News